Prominent Movement Disorders in <scp>RNU2</scp> ‐2‐Related Spliceosomopathy
Pediatric movement disorders often overlap with neurodevelopmental diseases, suggesting shared molecular mechanisms. Variants in small nuclear RNA (snRNA) genes encoding spliceosome components have recently been associated with neurodevelopmental disorders, termed "RNUopathies." We analyzed genome sequencing data from 14 patients with undiagnosed pediatric movement disorders for pathogenic variants in snRNA genes. We identified recurrent de novo RNU2-2 variants (n.35A > G and n.4G > A) in two patients with intellectual disability, epilepsy, and hyperkinetic movement disorders. RNA sequencing of fibroblasts in one patient showed no characteristic transcriptomic signature. Spliceosomopathies should be considered in neurodevelopmental disorders and developmental and epileptic encephalopathies with hyperkinetic features.
Authors
- Magdalena Krygier (ORCID: https://orcid.org/0000-0002-6607-5983)
- Anna Lemska (ORCID: https://orcid.org/0000-0003-0519-9007)
- Ugo Sorrentino (ORCID: https://orcid.org/0000-0001-8139-6198)
- M Wagner
- Maria Mazurkiewicz‐Bełdzińska (ORCID: https://orcid.org/0000-0002-9405-5066)
- Michael Zech (ORCID: https://orcid.org/0000-0001-8112-9153)
- Marta Zawadzka (ORCID: https://orcid.org/0000-0003-4562-1882)
Institutions
- Helmholtz Zentrum München (DE)
- Institute for Advanced Study (DE)
- Technical University of Munich (DE)
- Gdańsk Medical University (PL)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1002/acn3.70442
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.00